I live with Psoriasis.
I’ve had it since 2000/2001.
My Enbrel shots were losing efficiency over time and I’ve been invited to take part in a clinical trial from Boehringer Ingelheim.
It’s a blind test, so I’ll be injecting either Humira or BI’s new compound: BI 655066.
BI 655066 is an anti-IL-23 monoclonal biologic antibody.
The trial is taking place for 16 weeks, and is targeted at patients in which treatment with adalimumab resulted in inadequate response.
Treatment started September 19th.
I just want to be clear of skin lesions and feel no pain on my hands, scalp, feet, legs :(
Why again, you ask?
Because I’ve already taken part of a clinical trial for AMGEN, for a phase III testing of brodalumab. That was an amazing experience. No big complications, no side effects (that I know of). Went from the worst I’ve been regarding Psoriasis to clean in a few weeks, remained clean for the duration of the trial.
Apparently Amgen backed off the trial and the drug itself because of reported, and I quote, “events of suicidal ideation and behavior”.
AstraZeneca and Valeant Pharmaceuticals are now in charge of the drug.
PS: A big thank you to the Portuguese Health System because i wouldn’t be able to afford Enbrel for the life of me…